MALLEO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 19.641
EU - Europa 16.382
AS - Asia 11.406
SA - Sud America 1.749
Continente sconosciuto - Info sul continente non disponibili 538
AF - Africa 398
OC - Oceania 40
AN - Antartide 1
Totale 50.155
Nazione #
US - Stati Uniti d'America 18.817
RU - Federazione Russa 6.181
SG - Singapore 4.437
CN - Cina 3.238
GB - Regno Unito 2.653
IT - Italia 2.638
BR - Brasile 1.352
HK - Hong Kong 997
VN - Vietnam 997
DE - Germania 969
FR - Francia 925
IE - Irlanda 765
SE - Svezia 757
FI - Finlandia 437
CA - Canada 397
BD - Bangladesh 340
KR - Corea 325
NL - Olanda 229
IN - India 225
JP - Giappone 179
UA - Ucraina 157
MX - Messico 140
AR - Argentina 132
ES - Italia 129
TR - Turchia 101
ID - Indonesia 93
NG - Nigeria 92
PL - Polonia 92
IQ - Iraq 80
ZA - Sudafrica 71
AT - Austria 70
PK - Pakistan 64
BE - Belgio 60
CO - Colombia 56
CR - Costa Rica 55
EC - Ecuador 54
LT - Lituania 44
CZ - Repubblica Ceca 43
VE - Venezuela 42
TG - Togo 37
MA - Marocco 35
PH - Filippine 34
AU - Australia 33
CL - Cile 33
BJ - Benin 31
CH - Svizzera 30
HN - Honduras 30
PY - Paraguay 30
TN - Tunisia 29
UZ - Uzbekistan 29
SV - El Salvador 28
TT - Trinidad e Tobago 28
GT - Guatemala 27
NP - Nepal 27
AE - Emirati Arabi Uniti 26
EG - Egitto 26
JM - Giamaica 26
SA - Arabia Saudita 25
CW - ???statistics.table.value.countryCode.CW??? 24
JO - Giordania 24
NI - Nicaragua 24
PE - Perù 24
RO - Romania 24
IL - Israele 23
KE - Kenya 21
PR - Porto Rico 20
DZ - Algeria 18
AZ - Azerbaigian 17
GR - Grecia 17
MY - Malesia 16
TH - Thailandia 16
DK - Danimarca 15
EE - Estonia 15
HU - Ungheria 14
LV - Lettonia 14
PT - Portogallo 14
GP - Guadalupe 12
KG - Kirghizistan 12
AL - Albania 11
NO - Norvegia 11
SI - Slovenia 11
HR - Croazia 10
IR - Iran 10
KZ - Kazakistan 10
RS - Serbia 10
UY - Uruguay 10
BG - Bulgaria 9
BO - Bolivia 9
PS - Palestinian Territory 9
BB - Barbados 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
OM - Oman 7
LB - Libano 6
NZ - Nuova Zelanda 6
BA - Bosnia-Erzegovina 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
BH - Bahrain 4
BS - Bahamas 4
Totale 49.537
Città #
Ashburn 2.722
Singapore 2.308
Moscow 2.174
Southend 2.152
Dallas 1.949
San Jose 1.930
Chandler 1.500
Hong Kong 975
Verona 811
Council Bluffs 787
Dublin 737
Beijing 603
The Dalles 512
Jacksonville 510
Woodbridge 494
New York 456
Houston 388
Los Angeles 351
Ho Chi Minh City 344
Ann Arbor 306
Munich 295
Lawrence 243
Princeton 243
Santa Clara 240
Wilmington 218
Hanoi 215
Jinan 215
Nanjing 178
Helsinki 175
São Paulo 161
Shenyang 157
Milan 149
Boardman 147
Buffalo 146
Tokyo 146
Redondo Beach 142
Orem 138
Hebei 118
Redmond 111
Columbus 102
Montreal 102
Rome 102
London 97
Sindelfingen 96
Tianjin 94
Turku 94
Atlanta 92
Seattle 90
Chicago 87
Denver 84
Abuja 83
Frankfurt am Main 83
Haikou 79
Brooklyn 77
Bologna 76
Phoenix 76
Toronto 75
Hangzhou 73
San Francisco 72
Chennai 71
Amsterdam 69
Warsaw 69
Zhengzhou 69
Changsha 68
Ningbo 68
Stockholm 62
Guangzhou 57
Fairfield 54
Nanchang 53
Poplar 53
Brussels 52
Mexico City 52
Da Nang 51
Taizhou 49
Falkenstein 48
Lancaster 48
Redwood City 48
Seoul 48
Johannesburg 47
Rio de Janeiro 47
Haiphong 45
Taiyuan 45
Washington 45
Jiaxing 44
San José 43
Nuremberg 42
Mumbai 39
Vienna 38
Baghdad 37
Belo Horizonte 37
Lomé 37
Paris 37
Manchester 36
Jakarta 34
Lappeenranta 34
North Bergen 32
Cotonou 31
Boston 30
Brasília 30
Philadelphia 30
Totale 29.109
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 1.033
STUDIO PROSPETTICO MULTICENTRICO SULLA GESTIONE DEI DRENAGGI DOPO DUODENOCEFALOPANCREASECTOMIA UTILIZZANDO UN SISTEMA DI STRATIFICAZIONE DEL RISCHIO 841
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 407
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 402
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 326
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 304
Genomic characterization of hepatoid tumors: context matters 275
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 268
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 263
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 263
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 261
Gα15 in early onset of pancreatic ductal adenocarcinoma 253
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 250
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 248
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 243
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 242
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 239
Delaying surgery for patients with a previous SARS-CoV-2 infection 236
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 234
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 234
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 232
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 230
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 229
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 228
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 226
Sex differences in oncogenic mutational processes 226
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 226
Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases 223
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 223
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 222
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 221
Acute pancreatitis at the beginning of the 21st century: the state of the art. 220
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 220
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 219
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 217
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 216
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 214
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 212
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 212
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 211
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 209
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 206
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 203
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 203
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 202
Efficacy of Endoscopic Minor Papilla Sphincterotomy for Symptomatic Santorinicele Endoscopic treatment of Santorinicele 199
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 198
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 197
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 196
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 195
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 195
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 195
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 195
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 194
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 194
Immune performance profile in pancreatic adenocarcinoma patients. 193
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 193
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 192
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 192
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 192
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 192
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 191
An unforeseeable adverse event during ERCP 190
Results of a surveillance protocol for pancreatic BD-IPMNs 190
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 190
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 188
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 187
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 187
Serous Cystic Neoplasms 186
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 186
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 186
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 185
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 184
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 184
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 184
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 183
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 183
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 183
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 183
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 183
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 182
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 182
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 182
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons 181
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 180
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 179
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 179
ASO Visual Abstract: Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver 178
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 178
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or~Tail on Surgical and Oncological Outcome: A Propensity-Score~Matched Multicenter Study 178
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 178
Cystic Neoplasm of the Pancreas 177
CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas 177
The management of intraductal papillary mucinous neoplasms of the pancreas 176
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 176
Local ablation disrupts immune evasion in pancreatic cancer 175
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 175
An Antibiotic Stewardship Program in Pancreatic Surgery 175
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 174
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 174
Totale 22.473
Categoria #
all - tutte 174.719
article - articoli 164.515
book - libri 0
conference - conferenze 2.694
curatela - curatele 0
other - altro 2.687
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.823
Totale 349.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.145 0 0 0 139 59 34 33 127 98 51 139 465
2022/20234.811 291 521 401 765 398 1.324 114 307 473 53 97 67
2023/20242.660 88 217 261 277 281 417 169 221 47 102 429 151
2024/20256.738 356 335 248 1.027 359 203 420 345 996 497 664 1.288
2025/202622.558 1.417 1.390 1.636 3.575 5.367 1.410 1.880 1.330 1.927 1.322 517 787
2026/20274.390 472 647 868 2.403 0 0 0 0 0 0 0 0
Totale 50.155